Created at Source Raw Value Validated value
Nov. 28, 2021, 11 p.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsAfter selection and enrolment and after obtaining and informed consent subjects will be assigned to one of four groups to to receive, in addition to the usual care as directed by national guideline, one of the four treatments. In GROUP1 the subject will receive bromhexine hydrochloride tablets16 mg every 8 hours for 14 days plus hydroxychloroquine tablets 400mg every 12 hours on day 1 and 200 mg every 12 hours on days 2 to five.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group 2: After selection and enrolment and after obtaining and informed consent subjects will be assigned to one of four groups to to receive, in addition to the usual care as directed by national guideline, one of 4 treatments. In GROUP 2 the subject will receive bromhexine hydrochloride tablets16 mg every 8 hours for 14 days plus placebo of hydroxychloroquine tablets for five days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group 3: After selection and enrolment and after obtaining and informed consent subjects will be assigned to one of four groups to to receive, in addition to the usual care as directed by national guideline, one of the four treatments. In the group 3 the subject will receive hydroxychloroquine tablets 400mg every 12 hours at day one and 200 mg every 12 hours at days 2 to five + placebo of bromhexine for 14 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: After selection and enrolment and after obtaining and informed consent subjects will be assigned to one of four groups to to receive, in addition to the usual care as directed by national guideline, one of the four treatments. In the control group (group 4) the individual will receive just placebo for bromhexine hydrochloride for 14 days and hydroxychloroquine for 5 days.", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": 1545, "treatment_name": "Bromhexine+hydroxychloroquine", "treatment_type": "Respiratory agents+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 240, "treatment_name": "Bromhexine hydrochloride", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}]